Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)

BJU International, 06/06/2011

Dutasteride and finasteride, when administered for 12 months, were similarly effective in reducing prostate volume and improving maximum urinary flow rate (Qmax) and urinary symptoms associated with benign prostatic hyperplasia (BPH) in men with an enlarged prostate.

Print Article Summary Cat 2 CME Report